Chordate Medical

Bergs Securities acted as financial adviser to Paxman in the recommended public offer for Dignitana

The merger between Paxman and Dignitana creates a new group. Paxman and Dignitana have been active in scalp cooling, for many years as clear leaders in the market. The merger provides synergies for the new group through increased revenues and reduced costs through rationalisation but also economies of scale. This provides exciting growth opportunities and improved profit margins, enabling further investment in market expansion and research and development. Combining the best parts of the companies brings not only commercial benefits but also customer and patient benefits leading to improved shareholder value.